Rejection Normal response Inflammation 25% of pt. will have acute rejection during the first year post transplant Causes: Previous Rejection Noncompliance.

Slides:



Advertisements
Similar presentations
Research By: Dr. Ritta Baena Visual Effects By: John Baena
Advertisements

Left Ventricular Assist Devices “LVAD”
Assisted Circulation MEDICAL MEDICAL  Drugs  EECP MECHANICAL  IABP ( Introaortic balloon pump)  VAD (Ventricular assist device)
Respiratory Failure/ ARDS
MO CKD This material was prepared by Primaris, the Medicare Quality Improvement Organization for Missouri, under contract with the Centers for Medicare.
NxStage Kidney Care Encourage,Enhance,Empower Crystal Dean RN
Congestive heart failure guideline. Functional classification( NYHA) Class IV: symptoms at rest Class III: symptoms on less-than-ordinary exertion Class.
Can Comparative Effectiveness Study Tell Us What Is The Best Therapy For Class IV Heart Failure? Beta blockers or LVADs?
Pre-operative Physiotherapy in Oesophageal Surgery
Core practice skills for adult critical care dedicated Prepared By Randa Mamdouh Under Supervision of Assist. Prof. Dr/ Salwa Samir Medical Surgical Nursing.
Topics Zoll LifeVest  What it is  Who it treats  How does EMS handle these patients?
Preparation for postural drainage
By: Mark Torres Anatomy and Physiology II TR 3:15- 6:00.
Case Studies Advanced Heart Failure and the Role of Mechanical Circulatory Support Megan Shifrin, RN, MSN, ACNP-BC Vanderbilt University.
Left Ventricular Assist Devices: The What and the Who Lance E. Sullenberger MD FACC FACP Capital Cardiology Associates.
Community Preparation for Caring for Mechanical Circulatory Device Patients University of Wisconsin Hospital And Clinics Ventricular Assist Device Program.
By: Nermine Mounir Assistant prof. chest Department, Ain Shams University.
Dean Handimulya UIEU 2005 Congestive Heart Failure Dean Handimulya, M.D.
The Benefits of Cardiac Rehabilitation By: Jenna Kong  An overview for people that are interested in participating in a program.
Kim Dosch, PT Tina Fields, PT, CCS 06/20/2013
Ventricular Assist Devices Brian Schwartz, CCP February 25, 2003.
Advances In LVAD Patient Management
Introduction to Ventricular Assist Device (VAD)
Supporting Patients with CHF Care Transformation Collaborative of R.I. MAUREEN CLAFLIN, MSN, RN. NCM UNIVERSITY MEDICINE GOVERNOR STREET PRIMARY CARE CENTER.
9/5/20151 Ventricular Assist Device (VAD) Patients in the Community Liz Amerman, RN, BSN IU Health Methodist VAD Program Manager April 18, 2012.
Silver Cross EMSS March 2013 EMD CE LVAD.
Biventricular Failure – Total Artificial Heart Francisco A. Arabía, MD Director, CHSI Center for Surgical Device Management Cedars-Sinai Heart Institute.
IABP, VAD, ICD & Pacemaker Therapies Diane E. White RN CCRN PhD.
Transition to Next Level of Care Management of Patient with Ventricular Assist Device Hospital Home Transition.
Copyright © 2008 Delmar Learning. All rights reserved. Unit 36 Subacute Care.
Community Preparation for Caring for Mechanical Circulatory Device Patients University of Wisconsin Hospital And Clinics Ventricular Assist Device Program.
Extracorporeal Membrane Oxygenation
Cardiac Cath and Angiocardiography SPRING 2009 FINAL
You Are Now Entering The IMC/TeleUNIT. Designed to provide care for those who need less monitoring than those in the Intensive Care units, but, still.
Ventricular Assist Devices A Ventricular assist device, or VAD, is a mechanical circulatory device that is used to partially or completely replace the.
Chapter 28 and 29 Post Surgical Rehabilitation. Overview Although many musculoskeletal conditions can be treated conservatively, surgical intervention.
Early Mobilization of LVAD Recipients Christiane S. Perme, PT, Robert E. Southard, MD, David L Joyce, MD George P Noon, MD, Matthias Loebe, MD, PhD Tex.
Professor Davor Miličić, MD, PhD, FESC MECHANICAL SUPPORT TO THE FAILING HEART Department of Cardiovascular Medicine, Zagreb University School of Medicine,
Pediatric Mechanical Circulatory Support (MCS) Ivan Wilmot, MD Heart Failure, Transplant, MCS Assistant Professor The Heart Institute Cincinnati Children’s.
BME 301 Lecture Nineteen. Progression of Heart Disease High Blood Pressure High Cholesterol Levels Atherosclerosis Ischemia Heart Attack Heart Failure.
Clinical Review AbioCor® Implantable Replacement Heart H Julie Swain M.D. Cardiovascular Surgeon Ileana Piña M.D. Heart Failure Cardiologist DRAFT.
 39 year old Male  Single, no children  Lives in a 2 story home alone?  Lives in a 1 story home with brother?  Lives in a 3 story home with sister?
Ventricular Assist Device: Intervals for dressing changes By. Megan Giska.
Cardiac Cath and Angiocardiography Adult II FINAL 2/2015.
Advanced Therapies Lee R. Goldberg, MD, MPH Medical Director, Heart Failure and Cardiac Transplant Program University of Pennsylvania.
Subacute Care Chapter 25 Subacute Care Care for Residents With Specific Needs Formerly cared for in Hospital Rehabilitation Complicated Respiratory Care.
CARDIOHELP TRAINING June 18-19, 2013
Heart Failure Cardiac Insufficiency. What is Heart Failure? Heart failure is a progressive disorder in which damage to the heart causes weakening of the.
BME 301 Lecture Nineteen. Progression of Heart Disease High Blood Pressure High Cholesterol Levels Atherosclerosis Ischemia Heart Attack Heart Failure.
Extracorporeal Membrane Oxygenation for Bridge to Decision and to Recovery Shigeki Tabata, Hitoshi Hirose, Nicholas C. Cavarocchi, James T. Diehl, Hiroyuki.
Presented by Nai-Hsin Chi National Taiwan University Hospital
DR. MOHAMED SEYAM PHD. PT. ASSISTANT PROFESSOR OF PHYSICAL THERAPY PROTOCOL FOR CARDIAC REHABILITATON.
ECMO Extracorporeal membrane oxygenation
CORONARY ARTERY DISEASES DR. MOHAMED SEYAM PHD. PT. Assistant Professor Of Physical Therapy For Cardiovascular/Respiratory Disorder.
PROTOCOL FOR CARDIAC REHABILITATON Patient assessment ↓Evaluation↓ Treatment plan ↓ Pre operative evaluation ↓ Post operative evaluation ↓ Home program.
CARDIAC REHABILITATION By Dr. Prashant P. Kashyap Dr. Prashant P. Kashyap Chief physiotherapist Vikram hospital pvt. Ltd.
BME 312 BIOMEDICAL INSTRUMENTATION II LECTURER: ALİ IŞIN LECTURE NOTE 2 BLOOD PUMPS BME 312-BMI II-L2-ALİ IŞIN 2015 FACULTY OF ENGINEERING DEPARTMENT OF.
What Causes End-Stage Heart Failure?
Ventricular Assist Device
Preoperative screening for LVAD an TAH implantation
Assist Devices for the Treatment of Cardiogenic Shock
Mechanical circulatory support
Management of Pulmonary Conditions
Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients  James K. Kirklin, MD, David C. Naftel,
Cardiac Cath NUR 422.
Mechanical Circulatory Support Devices HOSEIN PASANDI.
Chapter 33 Acute Care.
Durable Mechanical Circulatory Support in Advanced Heart Failure
Chapter 25 Respiratory Care Modalities
Presentation transcript:

Rejection Normal response Inflammation 25% of pt. will have acute rejection during the first year post transplant Causes: Previous Rejection Noncompliance High cholesterol

3 Kinds of Rejection Hyper-acute: happens immediately Acute: within 1 month of transplant Chronic: all pts have this

Likely sources of rejection: 0-1 Month IV line infection Urinary tract infection Wound infection Pneumonia Human herpes simplex virus

Outcomes – Heart Transplant Hospital LOS Typical 15 Long Term Survival 3mo: 93% 1yr: 88% 5yr: 76% 10yr: 54%, can go 20+ years

Outcomes – Lung Transplant Hospital LOS 1-3 weeks Long Term Survival 3mo: 91% 1yr: 80% 5yr: 51% 10yr: 21%

Morbidity and Mortality Most common causes of death in patient’s with transplant are infection and rejection Most common complications for these patient’s are CVA, kidney failure, development of DM, muscle atrophy

Physical Therapy Goals Airway Clearance Patient Function Patient Education Strengthening HEP Aerobic Training HEP Pacing, self-monitoring, targeting exercise, progression of HEP Discharge Plans

Mechanical Assist Devices Cardiac Ventricular Assist Device Total Artificial Heart Respiratory Venous-Venous Extracorporeal membrane oxygenation (ECMO) Cardiac and Respiratory Venous-Arterial Extracorporeal membrane oxygenation (ECMO)

Ventricular Assist Devices What is it? Purpose Placement: L side Attachments Equipment: pump implanted in body, runs a long cord to keep infection away.

Ventricular Assist Devices LVAD: RVAD: temporarily BiVAD: not good success Total Artificial Heart: bilateral heart failure

Purpose Temporary: usually because of complications or younger patients. Long Term Bridge to Transplant Bridge to Explant: wean off VAD Destination

Ventricular Assist Devices – History Technological Advances

Ventricular Assist Devices – Types Types Pneumatic Axial Flow: screw that spins fastly

Heartmate 2 Continuous Flow Significantly decreased pulse pressure Anticoagulation Hemolysis “Vitals” Flow: set rate Speed Power Pulsatility Index

Ventricular Assist Devices – Types Types Pneumatic Axial Flow Centrifugal Flow

HeartWare

Jarvik 2000

Total Artificial Heart Purpose: bilateral heart failure Differences: remove values Surgical Procedure: sternotomy ICU vs. Home Equipment

Total Artificial Heart

Ventricular Assist Devices Operative Procedure Median Sternotomy Benefits: able to be on wait list longer Risks: infection, clotting, bleeding, cognitive changes.

Lifestyle changes: 24 hour supervision: trained with VAD emergency. Stay away from water Restriction on recreation and exercise Restriction for static electricity Necessary equipment: back-up power in <5min.

Temporary / External VADS Purpose Types AbioMed Blood Pump 5000 Ventricles CentriMag Stay in ICU Functional Limitations

AbioMed Ventricle

CentriMag

Patient Video: CentriMag and Heartmate II

Veno-Venous Extracorporeal Membrane Oxygenation (ECMO) Arterial vs. Venous ECMO Purpose: used if there is heart and lung failure. Venous ECMO: Lines in jugular that take deO2 blood out, oxygenate it and then pumps it back in. Helps to improve condition for surgery

Patient Video: VVECMO

Implications For PT Physiology of LVAD Preload and afterload dependent BP (with axial or centrifugal flow) appropriate target for exercise intensity Arrhythmias AICD Lab Values-HgB/Antibodies Equipment Emergency Procedures

Post-Operative Course Post Transplant Or VAD ICU Course Multiple chest tubes, IV lines, A-line, swan- ganz, catheter, pulse ox, SCDs, telemetry Delayed sternal closure Intubated/Sedated PT POD #1 Focus on Early Mobility: winkleman “bed rest in hell and critical illness, a body systems approach”

Early Post-Op Course Day 1 common problem list Impaired airway clearance Decreased chest wall mobility Decreased functional mobility Decreased ROM and strength Limited knowledge of post-surgical precautions Other considerations Pressure relief / skin care Edema management

Early Post-Op Course Day 1 common treatment activities Airway clearance Breathing exercises Chest wall mobility Positioning for postural drainage and edema management Shoulder exercises Bed mobility Transfer to chair Initiate patient/family education Discharge planning

Early Post-Op Course Day 2-3 Continues in ICU usually PA catheter and A-line are taken out Continue with day 1 treatment activities adjust and progress as necessary Progress ambulation

Early Post-Op Course Day 4-14: Moves out of ICU Teach independent airway clearance Progress mobility/activity Begin stair climbing Nu-Step or treadmill training Aerobic home exercise program Strengthening home exercise program Functional Outcome Measures Complete patient/family education

For patients s/p transplant or LVAD: Issues Regarding Discharge Home Significant medication regime and side effects Frequent lab, procedure and MD appointments Changes in physical appearance/return to intimacy Depression and mood disorders Stress on finances and social support system

Outpatient Treatment Options Outpatient Cardiac Rehabilitation VADs not covered Outpatient Pulmonary Rehabilitation Outpatient PT (for VADs - comfort level of therapists?) Subacute rehab, acute rehab, etc.